Oncology Handbook
Interactive Reference
Home
Regimens
Color theme
Home
Regimens
Home
Neuroendocrine Tumours
Regimens
Neuroendocrine Tumours
77 regimens
Subsite
All
Adrenocortical Carcinoma
Extrapulmonary Poorly Differentiated: Neuroendocrine Carcinoma/Large or Small Cell Carcinoma/Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm
GI tract well-differentiated Grade 1/2 NETs
GI tract, Lung/Thymus, and Pancreas well-differentiated Grade 1/2 NETs
Gastroenteropancreatic NETs
Lung/Thymus well-differentiated NETs
Pancreas well-differentiated Grade 1/2 NETs
Pheochromocytoma/Paraganglioma
SSTR-Negative Disease of Well-Differentiated Grade 1/2 NETs
Well-Differentiated Grade 3 NETs, favorable biology
Well-Differentiated Grade 3 NETs, unfavorable biology
Intent
All
Adjuvant
Neoadjuvant
First-line
Metastatic
Other
Line
All
Adjuvant/Neoadjuvant
First-line
Any
Search
Reset
Regimen
Setting
Modality
Drugs
Evidence
Category
No regimens match your filters
← Prev
Next →
Regimen Detail
Drugs
Drug
Dose
Route
Schedule
Trial Evidence
Trial
Phase
N
Primary Endpoint
OS
PFS/rPFS
ORR
Key Outcomes
Biomarkers
Marker
Requirement
Mandatory
Required
Optional
Notes